Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) emerged in China, causing a global pandemic with severe, multi-systemic complications.
• The virus's rapid spread and high mortality rate necessitate urgent research into its pathogenesis and effective treatments.
• Noncoding RNAs (ncRNAs) are increasingly recognized for their roles in viral infections and host immune responses.

Purpose of the Study:

• To review the molecular biology of SARS-CoV-2.
• To elucidate the role of ncRNAs in SARS-CoV-2 infection and host immune responses.
• To explore potential RNA-based therapeutic strategies against SARS-CoV-2.

Main Methods:

• Literature review of recent research on SARS-CoV-2 and ncRNAs.
• Analysis of molecular mechanisms underlying viral infection and immune modulation by ncRNAs.
• Synthesis of information on current and emerging RNA therapy tactics.

Main Results:

• ncRNAs play a significant role in modulating SARS-CoV-2 entry, replication, and pathogenesis.
• Specific ncRNAs are implicated in regulating the host's antiviral immune reactions.
• Evidence suggests ncRNAs can be targeted for therapeutic interventions against SARS-CoV-2.

Conclusions:

• Understanding the intricate interplay between SARS-CoV-2 and ncRNAs is vital for comprehending disease progression.
• Targeting ncRNAs presents promising avenues for developing novel antiviral therapies.
• Further research into ncRNA-based strategies could lead to effective treatments for COVID-19.